CartiFix

Cartifix is a medical adhesive powder used in cartilage repair procedures, specifically designed for knee surgeries. Combining mussel adhesive protein (MAP) and hyaluronic acid, this water-resistant coacervate is applied after micropuncture to retain bone marrow stem cells at the treatment site.
Ideal for athletes and the elderly, Cartifix supports hyaline cartilage regeneration, enhancing joint function and reducing pain. Its injectability and strong adhesion make it particularly effective in challenging joint environments, offering a robust solution where traditional hydrogels and sealants fail.

Cartifix is a dried powder coacervate combining mussel adhesive protein (MAP) and hyaluronic acid, with MAP produced via a biosynthetic E. coli cultivation system, ensuring ecological sustainability. The coacervate’s unique water-resistant formulation is crucial for maintaining bone marrow stem cells at the treatment site, particularly in knee joint surgeries where traditional hydrogels fail. Cartifix’s strong adhesive properties ensure reliable integration between regenerated and existing tissues, vital for effective knee cartilage repair. Its formulation resists degradation by matrix metalloproteinases (MMPs), enhancing durability in osteoarthritic conditions. The powder form offers easy injectability, streamlining minimally invasive knee procedures and improving outcomes for athletes, elderly patients, and other injured people.

Cartifix’s design prioritizes ease of use, ecological sustainability, and effectiveness in knee surgeries. The dried powder form offers excellent injectability, simplifying application during knee surgeries and promoting seamless integration with existing tissues for effective cartilage
regeneration. Its water-resistant properties ensure integrity in the knee joint environment, where traditional hydrogels may fail. Produced through a biosynthetic process that eliminates the need for animal-derived materials, Cartifix reduces environmental impact. The product’s distribution focuses on medical institutions and multinational pharmaceutical companies, ensuring accessibility to athletes, elderly patients, and other populations requiring knee cartilage repair.

Innovation #1 (Water-resistant retention): Cartifix’s innovative coacervate sets a new standard in knee cartilage repair by maintaining stem cells at the injury site, outperforming traditional hydrogels that rapidly hydrolyze in joint environments.

Innovation #2 (Superior adhesion): It offers stronger tissue adhesion compared to fibrin sealants, ensuring more reliable and effective tissue integration, crucial for successful knee cartilage regeneration.
Innovation #3 (Resilience in osteoarthritic conditions): The product resists degradation by MMPs and hyaluronidase, making it a durable solution in environments where other materials may fail.